- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 147 Pages
Global
From €4668EUR$4,949USD£3,916GBP
- Report
- March 2023
- 162 Pages
Global
From €3395EUR$3,599USD£2,848GBP
- Report
- March 2025
- 228 Pages
Global
From €2358EUR$2,500USD£1,978GBP
- Report
- November 2024
- 157 Pages
Global
From €2358EUR$2,500USD£1,978GBP
- Report
- July 2024
- 153 Pages
Global
From €2358EUR$2,500USD£1,978GBP
- Report
- May 2024
- 178 Pages
Global
From €2358EUR$2,500USD£1,978GBP
- Report
- November 2023
- 152 Pages
United States
From €2358EUR$2,500USD£1,978GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more